-
公开(公告)号:US20200017836A1
公开(公告)日:2020-01-16
申请号:US16471312
申请日:2017-12-19
Applicant: Osaka University
Inventor: Masahiro Kinooka , Meehae Kim , Yukako Fujinaga
IPC: C12N5/074
Abstract: Provided are a method for promoting the proliferation of pluripotent stem cells and a proliferation promoting composition used in the method. In one aspect, a composition for promoting the proliferation of pluripotent stem cells includes hemagglutinin or modified hemagglutinin. In another aspect, a method for promoting the proliferation of pluripotent stem cells includes culturing pluripotent stem cells in a culture medium to which the proliferation promoting composition of the present disclosure has been added.
-
公开(公告)号:US20170196970A1
公开(公告)日:2017-07-13
申请号:US15315015
申请日:2015-06-02
Applicant: OSAKA UNIVERSITY
Inventor: Nao Jonai , Yukako Fujinaga , Masahiro Yutani , Yo Sugawara , Takuhiro Matsumura
IPC: A61K39/39 , A61K39/145
CPC classification number: A61K39/39 , A61K39/02 , A61K39/04 , A61K39/08 , A61K39/09 , A61K39/095 , A61K39/102 , A61K39/12 , A61K39/125 , A61K39/13 , A61K39/145 , A61K39/15 , A61K39/155 , A61K39/165 , A61K39/20 , A61K39/21 , A61K39/215 , A61K39/235 , A61K39/245 , A61K39/25 , A61K39/29 , A61K2039/541 , A61K2039/543 , A61K2039/55516 , Y02A50/386 , Y02A50/39 , Y02A50/466 , Y02A50/472
Abstract: An object of the present invention is to provide an adjuvant for a mucosal vaccine with high safety that induces a sufficient immune response in a mucosal membrane. According to the present invention, an adjuvant for a mucosal vaccine containing a protein complex composed of hemagglutinin (HA) subcomponents HA1 and HA2, and mutant subcomponent HA3 of botulinum toxin is provided.
-
公开(公告)号:US11795438B2
公开(公告)日:2023-10-24
申请号:US16471312
申请日:2017-12-19
Applicant: Osaka University
Inventor: Masahiro Kinooka , Meehae Kim , Yukako Fujinaga
IPC: C12N5/074
CPC classification number: C12N5/0696 , C12N2501/998
Abstract: Provided are a method for promoting the proliferation of pluripotent stem cells and a proliferation promoting composition used in the method. In one aspect, a composition for promoting the proliferation of pluripotent stem cells includes hemagglutinin or modified hemagglutinin. In another aspect, a method for promoting the proliferation of pluripotent stem cells includes culturing pluripotent stem cells in a culture medium to which the proliferation promoting composition of the present disclosure has been added.
-
4.
公开(公告)号:US11230701B2
公开(公告)日:2022-01-25
申请号:US15321835
申请日:2015-06-29
Applicant: Osaka University
Inventor: Masahiro Kinooka , Meehae Kim , Yukako Fujinaga , Yo Sugawara
Abstract: Provided are a novel hemagglutinin that can remove cells deviated from the undifferentiated state, the cells being cells that emerge in a colony during culture of stem cells having pluripotency, and a novel method for culturing stem cells having pluripotency, the method using hemagglutinin. Provided is a mutant hemagglutinin complex protein derived from Clostridium botulinum type B, the complex protein containing at least subcomponents HA2 and HA3 of hemagglutinin derived from Clostridium botulinum type B, and the complex protein containing amino acids constituting a glycosylation site, with at least one of the amino acids having been mutated. Provided is a method for culturing stem cells having pluripotency, the method including culturing the stem cell having pluriopotency in the presence of a mutant hemagglutinin complex protein of the present disclosure.
-
公开(公告)号:US20160324960A1
公开(公告)日:2016-11-10
申请号:US15223566
申请日:2016-07-29
Applicant: DAIICHI SANKYO COMPANY, LIMITED , OSAKA UNIVERSITY
Inventor: Yukako Fujinaga , Takuhiro Matsumura , Masahiro Yutani , Nao Jonai
IPC: A61K39/39 , A61K39/145 , C12N7/00 , C07K14/33
CPC classification number: A61K39/39 , A61K39/00 , A61K39/02 , A61K39/12 , A61K39/145 , A61K2039/5252 , A61K2039/541 , A61K2039/543 , A61K2039/55516 , A61K2039/55544 , A61K2039/575 , C07K14/33 , C07K14/77 , C07K2319/42 , C12N7/00 , C12N2760/16134 , Y02A50/386 , Y02A50/39 , Y02A50/466 , Y02A50/472
Abstract: An object of the present invention is to provide an adjuvant for a mucosal vaccine with high safety that induces a sufficient immune response on the mucosa. According to the present invention, an adjuvant for a mucosal vaccine comprising a protein complex composed of hemagglutinin (HA) subcomponents HA1, HA2, and HA3 of botulinum toxin is provided.
-
公开(公告)号:US20150329831A1
公开(公告)日:2015-11-19
申请号:US14655804
申请日:2013-12-26
Applicant: OSAKA UNIVERSITY
Inventor: Masahiro Kinooka , Meehae Kim , Yukako Fujinaga , Yo Sugawara
IPC: C12N5/074
CPC classification number: C12N5/0696 , C12N2501/58 , C12N2501/734 , C12N2501/998
Abstract: Provided is a method by which cells deviated from the undifferentiated state, which emerge in a colony during culture of stem cells having pluripotency, can be removed. In one aspect, provided is a method for culturing stem cells having pluripotency, the method including performing cell culture in the presence of a substance that can inhibit cell-cell adhesion. In another aspect, provided is a method for removing cells deviated from the undifferentiated state, the cells being cells that have emerged or may possibly emerge during culture of stem cells having pluripotency, the method including performing cell culture in the presence of a substance that can inhibit cell-cell adhesion. In still another aspect, provided is a method for maintaining the undifferentiated state of stem cells having pluripotency, the method including performing cell culture in the presence of a substance that can inhibit cell-cell adhesion.
Abstract translation: 可以除去在具有多能性的干细胞的培养期间在殖民地中出现的未分化状态的细胞偏离的方法。 一方面,提供了培养具有多能性的干细胞的方法,所述方法包括在可抑制细胞粘附的物质存在下进行细胞培养。 在另一方面,提供了一种去除脱离未分化状态的细胞的方法,所述细胞是在具有多能性的干细胞的培养期间已经出现或可能出现的细胞,所述方法包括在可以存在的物质存在下进行细胞培养 抑制细胞粘附。 另一方面,提供一种用于维持具有多能性的干细胞的未分化状态的方法,所述方法包括在可抑制细胞 - 细胞粘附的物质存在下进行细胞培养。
-
公开(公告)号:US12173034B2
公开(公告)日:2024-12-24
申请号:US16766596
申请日:2018-11-22
Applicant: OSAKA UNIVERSITY
Inventor: Yukako Fujinaga , Sho Amatsu , Masahiro Kinooka
Abstract: The present invention provides a miniaturized hemagglutinin complex protein having function inhibitory activity against E-cadherin, wherein (a) all or a part of at least HA1 subcomponent, and/or a part of HA3 subcomponent are/is deleted, (b) regions in HA2 and HA3 subcomponents that contribute to binding with E-cadherin are present, and (c) the HA3 subcomponent is derived from Clostridium botulinum type A or type B, and an E-cadherin function inhibitor containing the hemagglutinin complex protein.
-
公开(公告)号:US10226529B2
公开(公告)日:2019-03-12
申请号:US15315015
申请日:2015-06-02
Applicant: OSAKA UNIVERSITY
Inventor: Nao Jonai , Yukako Fujinaga , Masahiro Yutani , Yo Sugawara , Takuhiro Matsumura
IPC: A61K39/00 , A61K39/02 , A61K39/08 , A61K39/09 , A61K39/04 , A61K39/39 , A61K39/095 , A61K39/102 , A61K39/12 , A61K39/125 , A61K39/13 , A61K39/145 , A61K39/15 , A61K39/155 , A61K39/165 , A61K39/20 , A61K39/21 , A61K39/215 , A61K39/235 , A61K39/245 , A61K39/25 , A61K39/29
Abstract: An object of the present invention is to provide an adjuvant for a mucosal vaccine with high safety that induces a sufficient immune response in a mucosal membrane. According to the present invention, an adjuvant for a mucosal vaccine containing a protein complex composed of hemagglutinin (HA) subcomponents HA1 and HA2, and mutant subcomponent HA3 of botulinum toxin is provided.
-
公开(公告)号:US09822344B2
公开(公告)日:2017-11-21
申请号:US14655804
申请日:2013-12-26
Applicant: OSAKA UNIVERSITY
Inventor: Masahiro Kinooka , Meehae Kim , Yukako Fujinaga , Yo Sugawara
IPC: C12N5/074
CPC classification number: C12N5/0696 , C12N2501/58 , C12N2501/734 , C12N2501/998
Abstract: Provided is a method by which cells deviated from the undifferentiated state, which emerge in a colony during culture of stem cells having pluripotency, can be removed. In one aspect, provided is a method for culturing stem cells having pluripotency, the method including performing cell culture in the presence of a substance that can inhibit cell-cell adhesion. In another aspect, provided is a method for removing cells deviated from the undifferentiated state, the cells being cells that have emerged or may possibly emerge during culture of stem cells having pluripotency, the method including performing cell culture in the presence of a substance that can inhibit cell-cell adhesion. In still another aspect, provided is a method for maintaining the undifferentiated state of stem cells having pluripotency, the method including performing cell culture in the presence of a substance that can inhibit cell-cell adhesion.
-
公开(公告)号:US09662386B2
公开(公告)日:2017-05-30
申请号:US15223566
申请日:2016-07-29
Applicant: OSAKA UNIVERSITY
Inventor: Yukako Fujinaga , Takuhiro Matsumura , Masahiro Yutani , Nao Jonai
CPC classification number: A61K39/39 , A61K39/00 , A61K39/02 , A61K39/12 , A61K39/145 , A61K2039/5252 , A61K2039/541 , A61K2039/543 , A61K2039/55516 , A61K2039/55544 , A61K2039/575 , C07K14/33 , C07K14/77 , C07K2319/42 , C12N7/00 , C12N2760/16134 , Y02A50/386 , Y02A50/39 , Y02A50/466 , Y02A50/472
Abstract: An object of the present invention is to provide an adjuvant for a mucosal vaccine with high safety that induces a sufficient immune response on the mucosa. According to the present invention, an adjuvant for a mucosal vaccine comprising a protein complex composed of hemagglutinin (HA) subcomponents HA1, HA2, and HA3 of botulinum toxin is provided.
-
-
-
-
-
-
-
-
-